Biopharmaceuticals & Biotherapeutics Industry Competitors

Achillion Pharmaceuticals is looking for the Achilles heel of infectious disease. The firm is developing biopharmaceutical treatments for infectious diseases, including antiviral treatments for HIV infection and hepatitis C, as well as antibacterials for fighting drug-resistant hospital-based infections....

Actelion Pharmaceuticals UK is the British arm of Swiss biotech firm Actelion. The drug manufacturer's product pipeline is based on its research of the endothelium, the single layer of cells between blood vessels and the blood that flows through them....

ActivX Biosciences figures that the more you knows about protein kinases, the easier it will be to inhibit them. That's the basis of its main product: a platform to profile protein kinases -- enzymes that regulate cell's signaling pathways. Its KiNativ platform has been launched for use by pharmaceutical and biotechnology companies as they develop the kinase inhibitors expected to make drug breakthroughs....

Adenosine Therapeutics believes that adenosine receptor subtypes is where it's at. The company developes and commercializes therapeutic compounds based on adenosine (an endogenous nucleoside) and its receptor subtypes. Adenosine Therapeutics is targeting drugs for treatment of conditions such as cardiac disease, diabetes, sickle cell anemia, and inflammatory disorders....

AdipoGenix is helping the fight against fat. The company hopes to develop a drug to prevent fat from being stored in adipose tissue. It has identified small molecule compounds that reduce mature fat cells formed from precursor cells, decrease the storage of fat, and increase the breakdown of fat....

Advanced Life Sciences is a biopharmaceutical company working to develop clinical and preclinical drug candidates for infectious disease, cancer, and inflammation. Its antibiotic candidate cethromycin is in clinical trials for treatment of respiratory infections and pneumonia....

AERES Biomedical develops therapeutic antibodies. The biopharmaceutical research company has developed more than 20 antibody candidates though collaborative partnerships with other biotech and pharmaceutical companies, many of which are in clinical trial stages....

ALK-Abelló is a leading producer of allergy vaccination pharmaceuticals. The company is the result of the merger of ALK-Abelló and the former holding company of Chr. Hansen, which makes natural ingredients for the food manufacturing, pharmaceutical, and agriculture industries....

AlphaVax is looking to be the top dog of vaccine makers. The company is developing new vaccines for cancers and infectious diseases such as HIV/AIDS, pandemic influenza, and other viral maladies. AlphaVax relies on a proprietary alphavaccine system for creating vaccines that genetically alter the disease or cancer cells and transform them into a vaccine when the cells attempt to replicate....

Antisoma is buying into cancer. This company scouts academic or cancer research institutions for promising new drug candidates to treat cancer. Once it brings those drugs into its pipeline, Antisoma conducts preclinical and clinical development of treatments for breast cancer, gastric cancer, non-small cell lung cancer, and ovarian cancer....

Applied Genetic Technologies Corporation (AGTC) is developing gene therapies for the treatment of acquired and inherited genetic diseases. Its lead product is a treatment for Alpha One Antitrypsin Deficiency (Alpha-1), which is an inherited cause of emphysema....

Scottish drug firm Ardana specializes in developing and marketing products focused on reproductive health. It has sold testosterone replacement therapy Striant SR, a treatment for male hypogonadism, in numerous European countries under a license from Columbia Laboratories....

Ark Therapeutics is loading its boat with therapies that target cancer and vascular disease. The biotech company has one product on the market in the UK and the US -- Kerraboot, a wound dressing that treats chronic leg and foot ulcers. Lead candidate Cerepro has shown promise in extending the lives of brain tumor patients....

Even though it was doing okay in Chemistry, ArQule has decided to major in Molecular Biology. The biotechnology firm had been providing chemistry services to help drugmakers discover new potential drug compounds. However, it has switched from being a helper to becoming a doer....

Astralis hopes Psoraxine is the cure for psoriasis; the question is whether it will cure the ailing company's financial woes. The company's lead product candidate, which is in clinical trials, could treat psoriasis by stimulating the immune system. Originally developed by Chairman Jose O'Daly as a vaccine for leishmaniasis, the drug showed promise in treated psoriasis....

Avalon Pharmaceuticals doesn't mind if genes express themselves -- but they should know that anything they express can and will be used against them if they lead to cancer. The biopharmaceutical firm develops cancer therapeutics based on its AvalonRx platform, which identifies compounds that would be best suited to advance in clinical drug development....

AVEO Pharmaceuticals' models don't pout, strut, or even turn heads -- unless you're a cancer drug researcher. The biotech firm is developing cancer models to uncover how genes mutate into tumors and how tumors progress through additional mutations. AVEO then builds genetic profiles of of such tumors and applies them to drug candidates in preclinical development to help predict actual human responses....

Avontec might not be hawking cosmetics door-to-door, but it will help clear up those skin problems. The biopharmaceutical development company is working to create a new class of anti-inflammatory drugs called decoy ODNs to treat chronic diseases of the respiratory system and skin, specifically asthma and psoriasis....

More than a catalyst for change, Biolex Therapeutics (formerly Biolex, Inc.) wants to be a catalyst for transmogrification. Biolex uses its LEX System and "Plantibodies" technologies for harvesting proteins from Lemna, an aquatic plant, and genetically transforming them into monoclonal antibodies for use in treating human diseases such as hepatitis C....

BioSyntech is a development-stage company specializing in the creation and development of biotherapeutic thermogels to be used for human tissue repair and therapeutic delivery. The BST-Gels are liquid at room temperature but solidify at human body temperature, and they are classified as medical devices by the FDA and other regulators....